Mustang Bio, Inc. (MBIO) vs Revelation Biosciences, Inc. (REVB)
A side-by-side comparison of Mustang Bio, Inc. and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
REVB
Revelation Biosciences, Inc.
$0.76HealthcareDelayed quote: Oct 6, 2026, 2:41 PM EDT
Total return — MBIO vs REVB
growth of $100 · dividends reinvested · last 6yMBIO -100.0% (-75.8%/yr)REVB -100.0% (-89.7%/yr)MBIO compounded faster over this window
Log scale — wide-divergence pair
MBIO REVB
MBIO vs REVB: by the numbers
- •MBIO is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | MBIO | REVB |
|---|---|---|
| P/B ratio | 0.46 | 0.30 |
Profitability
| Metric | MBIO | REVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -40.20% | -106.79% |
| ROIC | -45.77% | -104.28% |
Growth (annualized)
| Metric | MBIO | REVB |
|---|---|---|
| Total return CAGR (5Y) | -80.80% | -93.52% |
Frequently asked
- How have MBIO and REVB total returns compared?
- Over the past 5 years, MBIO delivered -80.80% and REVB delivered -93.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.